N&O Index Card Listings
Displaying 1-6 of 6 results.
Glaxo, Inc.
- Glaxo exec takes on new title; Mario seen as likely heir to chairmanship - Ja 1 92, 6C
- Sanders now chairman and CEO of Glaxo, Inc. - Ja 7 92, 1D
- Glaxo makes choice for marketing post; Executive (Morrow) to oversee new drugs' promotion - Ja 14 92, 1D
- Glaxo cuts cost to clinics; Move seen as effort to avoid mandates - Fe 5 92, 9C
- New drugs boost profits for Glaxo parent - Fe 21 92, 7C
- Glaxo chooses new VP for research, development (Niedel) - Mr 4 92, 9C
- Glaxo drug likely to cause fiscal pains as it cures migraines - Mr 29 92, 1F
- Glaxo contributes to Durham Service Corps - Ap 1 92, 9C
- How Zantac dethroned Tagamet; Glaxo parlayed slight edge over rival ulcer treatment into No. 1 - drug - Ap 12 92, 4F
- Stark portrait paints Merck in white, Glaxo in black - Ap 12 92, 4F
- Glaxo faces $1 billion decision; Dividend, acquisition among several options - Ap 19 92, 1F
- Glaxo Holdings, biotech firm form partnership - Ap 21 92, 1D
- Glaxo donates TB treatment - Ap 30 92, 10C
- Glaxo calendar upsets pharmacist; Firm apologizes for entry on generic drugs - My 8 92, 6C
- Glaxo gives prize ulcer pill a new, unique look - My 9 92, 12C
- Glaxo offers Durham a bargain for prime ballpark site - My 29 92, 2B
- Glaxo to market Zantac to treat new ailment - Jn 4 92, 7C
- Glaxo Holdings, Ivax to make new type of inhaler device - Jn 17 92, 9C
- Glaxo woods doctors from tent at boat races - Jy 19 92, 1F
- Glaxo drug (Zofran) gets big boost - Se 5 92, 8C
- Glaxo, Calif. firm forge research ties - Se 10 92, 10C
- 4 companies give boost to child care; Area firms to spend $189,000 - Se 11 92, 6C
- Glaxo receives award from Labor Department - Se 18 92, 6C
- Firms offer child care - Se 21 92, 1B
- FDA approval of Glaxo drug moving slowly - Oc 9 92, 6C
- New Glaxo product to be a first; Skin test kit will be non-prescription item - Oc 28 92, 9C
- Glaxo offers stock options to lower ranks - De 10 92, 7C
- Glaxo chief perceives Clinton support for innovation - De 16 92, 9C
- Glaxo executive (Ingram) will handle sales, marketing in No. 2 spot - De 22 92, 1D
- FDA approves Glaxo's migraine drug (Imitrex) - De 30 92, 1
Glaxo, Inc.
- 3 technical schools, chemical, drug firms join to teach skills - Fe 4 87 6B
- RTP drug firms thrive - Ap 12 87 1I
- Glaxo to fund bonus for Zebulon teacher - Ap 14 87 1C
- Glaxo drug could help hypertension patients - No 3 87 1D
- Glaxo plans warehouse in Zebulon - De 12 87 8B
- Glaxo seeks to sell non-prescription drug (Ranitidine) - De 23 87 5B
- Glaxo gets U.S. approval for new oral antibiotic (Zinacef) - De 30 87 8B
Glaxo, Inc.
- FBI accuses man (Benton) of stealing formula (from Glaxo) - Ja 5 86 27A
- Industry safeguards cited in spy arrest - Ja 6 86 1C
- Glaxo offers new Zantac tablet - Fe 28 86 5C
- Glaxo drug OK'd for use against reflux (Zantac) - Jn 24 86 4D
- FDA says Glaxo being 'misleading' (in promoting Zantac) - Jy 22 86 1D
- Ex-Glaxo employee convicted of trying to sell drug secrets - Jy 27 86 44A
- Glaxo buys 100 acres next to headquarters - Au 22 86 4B
- Glaxo selects new chief operating officer (Mario) - Se 3 9B
- Drug company will build research facility at UNC - Oc 9 86 1
- Glaxo to add 100 jobs at Zebulon drug plant - Oc 10 86 4B
- Glaxo to fund UNC-CH research facility - Oc 14 86 1C
- Glaxo-UNC contracts arranged in private - Oc 15 86 1
- Ulcer drug helps Glaxo sales rise 25% worldwide - Oc 15 86 6B
- Editorial: Deal behind closed doors - Oc 16 86 26A
- Glaxo to be allowed confidential research - Oc 17 86 1
- Glaxo pact won't violate campus policy - Oc 18 86 1C
- Editorial: Academic values tarnished - Oc 20 86 14A
- Glaxo settles one dispute, works on others with FDA - Oc 30 86 7B
- Can academic, corporate research mix? - No 23 86 1D
- Glaxo to employ 1,000 researchers by '90 - De 6 86 8B
- Glaxo, Roche to sell, promote oral drug jointly (Zinacef) - De 9 86 3D
- Book honors Glaxo for 2 drugs' discovery - De 31 86 5B
Glaxo, Inc.
- Firm to be based in Triangle gets green light on ulcer drug - My 7 83 1C
- 200 Glaxo workers settling in at RTP - Au 5 83 5C
Glaxo, Inc.
- Glaxo speeding up its expansion plans - My 23 84 3C
- Glaxo dedicates $40 million plant; expansion scheduled to begin soon - No 16 84 6C